Concepedia

Carlos G. Santos‐Gallego

CG

41

Publications

3.4K

Citations

28

H-Index

2003

Active since

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

Mount Sinai Hospital

Cardiovascular Institute of the South

Harvard University

Spanish National Centre for Cardiovascular Research

Carlos G. Santos‐Gallego is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, cardiovascular disease, and atherosclerosis.

ORCID

Top concepts

Publications per year

2003–2024

41

Publications

41

Empagliflozin Ameliorates Adverse Left Ventricular Remodeling in Nondiabetic Heart Failure by Enhancing Myocardial Energetics

Carlos G. Santos‐Gallego, Juan Antonio Requena-Ibáñez, Rodolfo San Antonio et al. · Journal of the American College of Cardiology · 2019 · 633 citations

, , +8

Randomized Trial of Empagliflozin in Nondiabetic Patients With Heart Failure and Reduced Ejection Fraction

Carlos G. Santos‐Gallego, Ariana P. Vargas-Delgado, Juan Antonio Requena-Ibáñez et al. · Journal of the American College of Cardiology · 2020 · 492 citations

, , +7

Mechanistic Insights of Empagliflozin in Nondiabetic Patients With HFrEF

Juan Antonio Requena-Ibáñez, Carlos G. Santos‐Gallego, Anderly Rodriguez-Cordero et al. · JACC Heart Failure · 2021 · 244 citations

, , +10

Empagliflozin Ameliorates Diastolic Dysfunction and Left Ventricular Fibrosis/Stiffness in Nondiabetic Heart Failure

Carlos G. Santos‐Gallego, Juan Antonio Requena-Ibáñez, Rodolfo San Antonio et al. · JACC. Cardiovascular imaging · 2020 · 183 citations

, , +9

Sphingosine-1-Phosphate Receptor Agonist Fingolimod Increases Myocardial Salvage and Decreases Adverse Postinfarction Left Ventricular Remodeling in a Porcine Model of Ischemia/Reperfusion

Carlos G. Santos‐Gallego, Torsten Vahl, Georg Goliasch et al. · Circulation · 2016 · 168 citations · Full text

Rows per page

1–5 of 41